158 related articles for article (PubMed ID: 15164304)
21. Mutation analysis of CDP, TP53, and KRAS in uterine leiomyomas.
Patrikis MI; Bryan EJ; Thomas NA; Rice GE; Quinn MA; Baker MS; Campbell IG
Mol Carcinog; 2003 Jun; 37(2):61-4. PubMed ID: 12766905
[TBL] [Abstract][Full Text] [Related]
22. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors.
Sgantzos MN; Galani V; Arvanitis LD; Charchanti A; Psathas P; Nakou M; Havaki S; Kallioras V; Marinos E; Vamvakopoulos NC; Kittas C
Pathol Res Pract; 2007; 203(1):31-7. PubMed ID: 17129677
[TBL] [Abstract][Full Text] [Related]
23. Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma.
Peng Y; Laser J; Shi G; Mittal K; Melamed J; Lee P; Wei JJ
Mol Cancer Res; 2008 Apr; 6(4):663-73. PubMed ID: 18403645
[TBL] [Abstract][Full Text] [Related]
24. Decreased expression of early growth response-1 and its role in uterine leiomyoma growth.
Shozu M; Murakami K; Segawa T; Kasai T; Ishikawa H; Shinohara K; Okada M; Inoue M
Cancer Res; 2004 Jul; 64(13):4677-84. PubMed ID: 15231681
[TBL] [Abstract][Full Text] [Related]
25. Gene expression studies in leiomyomata: new directions for research.
Catherino W; Salama A; Potlog-Nahari C; Leppert P; Tsibris J; Segars J
Semin Reprod Med; 2004 May; 22(2):83-90. PubMed ID: 15164303
[TBL] [Abstract][Full Text] [Related]
26. Tranexamic acid-associated necrosis and intralesional thrombosis of uterine leiomyomas: a clinicopathologic study of 147 cases emphasizing the importance of drug-induced necrosis and early infarcts in leiomyomas.
Ip PP; Lam KW; Cheung CL; Yeung MC; Pun TC; Chan QK; Cheung AN
Am J Surg Pathol; 2007 Aug; 31(8):1215-24. PubMed ID: 17667546
[TBL] [Abstract][Full Text] [Related]
27. Novel therapeutic strategies for leiomyomas: targeting growth factors and their receptors.
Nowak RA
Environ Health Perspect; 2000 Oct; 108 Suppl 5():849-53. PubMed ID: 11035994
[TBL] [Abstract][Full Text] [Related]
28. Polymorphism of the p53 tumor suppressor gene is associated with susceptibility to uterine leiomyoma.
Denschlag D; Bettendorf H; Watermann D; Keck C; Tempfer C; Pietrowski D
Fertil Steril; 2005 Jul; 84(1):162-6. PubMed ID: 16009172
[TBL] [Abstract][Full Text] [Related]
29. Critical roles for the Fas/Fas ligand system in postinfarction ventricular remodeling and heart failure.
Li Y; Takemura G; Kosai K; Takahashi T; Okada H; Miyata S; Yuge K; Nagano S; Esaki M; Khai NC; Goto K; Mikami A; Maruyama R; Minatoguchi S; Fujiwara T; Fujiwara H
Circ Res; 2004 Sep; 95(6):627-36. PubMed ID: 15297380
[TBL] [Abstract][Full Text] [Related]
30. Familial multiple cutaneous and uterine leiomyomas associated with papillary renal cell cancer.
Chan I; Wong T; Martinez-Mir A; Christiano AM; McGrath JA
Clin Exp Dermatol; 2005 Jan; 30(1):75-8. PubMed ID: 15663510
[TBL] [Abstract][Full Text] [Related]
31. Expression of apoptosis markers in the retinas of human subjects with diabetes.
Abu-El-Asrar AM; Dralands L; Missotten L; Al-Jadaan IA; Geboes K
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2760-6. PubMed ID: 15277502
[TBL] [Abstract][Full Text] [Related]
32. [Genetics of uterine leiomyomata].
Pedeutour F; Ligon AH; Morton CC
Bull Cancer; 1999 Nov; 86(11):920-8. PubMed ID: 10586108
[TBL] [Abstract][Full Text] [Related]
33. Loss of cyclin g1 expression in human uterine leiomyoma cells induces apoptosis.
Kwon SH; Park JC; Ramachandran S; Cha SD; Kwon KY; Park JK; Park JW; Bae I; Cho CH
Reprod Sci; 2008 Apr; 15(4):400-10. PubMed ID: 18497347
[TBL] [Abstract][Full Text] [Related]
34. Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma.
Leiser AL; Anderson SE; Nonaka D; Chuai S; Olshen AB; Chi DS; Soslow RA
Gynecol Oncol; 2006 Apr; 101(1):86-91. PubMed ID: 16289259
[TBL] [Abstract][Full Text] [Related]
35. Epigenomic and enhancer dysregulation in uterine leiomyomas.
Mlodawska OW; Saini P; Parker JB; Wei JJ; Bulun SE; Simon MA; Chakravarti D
Hum Reprod Update; 2022 Jun; 28(4):518-547. PubMed ID: 35199155
[TBL] [Abstract][Full Text] [Related]
36. Telomere repeat fragment sizes do not limit the growth potential of uterine leiomyomas.
Rogalla P; Rohen C; Hennig Y; Deichert U; Bonk U; Bullerdiek J
Biochem Biophys Res Commun; 1995 Jun; 211(1):175-82. PubMed ID: 7779084
[TBL] [Abstract][Full Text] [Related]
37. Comparative effects of heparin-binding epidermal growth factor-like growth factor on the growth of cultured human uterine leiomyoma cells and myometrial cells.
Wang J; Ohara N; Takekida S; Xu Q; Maruo T
Hum Reprod; 2005 Jun; 20(6):1456-65. PubMed ID: 15760954
[TBL] [Abstract][Full Text] [Related]
38. Microallelotyping defines novel regions of loss of heterozygosity in uterine leiomyomas.
Canevari Rde A; Pontes A; Rogatto SR
Mol Carcinog; 2005 Mar; 42(3):177-82. PubMed ID: 15605361
[TBL] [Abstract][Full Text] [Related]
39. Vitamin D inhibits myometrial and leiomyoma cell proliferation in vitro.
Bläuer M; Rovio PH; Ylikomi T; Heinonen PK
Fertil Steril; 2009 May; 91(5):1919-25. PubMed ID: 18423458
[TBL] [Abstract][Full Text] [Related]
40. Expression profile of several genes in human myometrium and uterine leiomyoma.
Roth TM; Klett C; Cowan BD
Fertil Steril; 2007 Mar; 87(3):635-41. PubMed ID: 17173903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]